Intra-Cellular Therapies Inc (NASDAQ:ITCI)

24.38
Delayed Data
As of Apr 20
 +0.02 / +0.08%
Today’s Change
12.67
Today|||52-Week Range
30.72
+38.13%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close24.36
Today’s open24.64
Day’s range24.21 - 25.20
Volume347,272
Average volume (3 months)213,397
Market cap$850.8M
Dividend yield--
Data as of 4:00pm ET, 04/20/2015

Growth & Valuation

Earnings growth (last year)+31.41%
Earnings growth (this year)-144.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-78.91%
P/E ratioNM
Price/Sales875.93
Price/Book5.96

Competitors

 Today’s
change
Today’s
% change
EGRXEagle Pharmaceutical...+3.67+6.62%
RPTPRaptor Pharmaceutica...-0.19-1.73%
RGLSRegulus Therapeutics...-0.12-0.69%
TKMRTekmira Pharmaceutic...-0.71-3.74%
Data as of 4:00pm ET, 04/20/2015

Financials

Next reporting dateMay 4, 2015
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$577.3K
Annual profit (last year)-$30.7M
Net profit margin-5,316.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
Chief Financial Officer, Secretary &
VP
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers